1. Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
- Author
-
Marianna Y, Kawashima-Vasconcelos, Maynara, Santana-Gonçalves, Djúlio C, Zanin-Silva, Kelen C R, Malmegrim, and Maria Carolina, Oliveira
- Subjects
CÉLULAS-TRONCO ,Scleroderma, Systemic ,Immune System ,Immunology ,Hematopoietic Stem Cell Transplantation ,Humans ,Immunology and Allergy ,Autoimmunity ,Transplantation, Autologous - Abstract
Systemic sclerosis (SSc) is a chronic autoimmune disease that includes fibrosis, diffuse vasculopathy, inflammation, and autoimmunity. Autologous hematopoietic stem cell transplantation (auto-HSCT) is considered for patients with severe and progressive SSc. In recent decades, knowledge about patient management and clinical outcomes after auto-HSCT has significantly improved. Mechanistic studies have contributed to increasing the comprehension of how profound and long-lasting are the modifications to the immune system induced by transplantation. This review revisits the immune monitoring studies after auto-HSCT for SSc patients and how they relate to clinical outcomes. This understanding is essential to further improve clinical applications of auto-HSCT and enhance patient outcomes.
- Published
- 2022
- Full Text
- View/download PDF